Yabin Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yabin Cheng has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Dieter A. Wolf
Westlake Laboratory of Life Sciences and Biomedicine, School of Medicine, Westlake University, Hangzhou 310024, China
11 shared publications - Guiyou Tian
Bio-pharmaceutical Lab, Life Science College, Northeast Agricultural University, Harbin 150030, China
4 shared publications Cheng Hu
State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China
3 shared publications- Cheng Hu
School of Pharmaceutical Sciences, Xiamen University, China
3 shared publications Guiyou Tian
State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China
3 shared publications- Haoran Duan
School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research & Innovation Center for Cell Stress Signaling, Xiamen University, Xiamen 361102, China
2 shared publications
Latest Publications
- Open Access
5’UTR-mediated retention of eIF3 on 80S ribosomes promotes co-translational folding of ER membrane proteins
Co-translational folding of nascent polypeptides is essential for protein function and cellular homeostasis. Ribosome-associated chaperones assist in this process, but coordination between their recruitment and translation initiation remains poorly understood. We report here that specific binding sites for eukaryotic translation initiation factor eIF3 within the 5’ untranslated regions (5’UTRs) of mRNAs promote its retention on 80S ribosomes during the synthesis of select endoplasmic reticulum (ER) membrane proteins. Disruption of these eIF3 binding sites leads to misfolding and sequestration of newly synthesized membrane proteins into ER whorls. Sequestration into ER whorls is exacerbated by HSP70 inhibition but can be rescued by overexpressing HSPA8 and HSPA1. Cross-linking assays reveal that 5’UTR binding sites stabilize eIF3–80S interactions during early elongation, facilitating recruitment of HSPA8 to ribosomes. These findings indicate that genetic instructions within 5’UTRs direct eIF3-mediated chaperone recruitment, ensuring proper co-translational folding of ER membrane proteins.
Open Access5’UTR-mediated retention of eIF3 on 80S ribosomes promotes co-translational folding of ER membrane proteins
Co-translational folding of nascent polypeptides is essential for protein function and cellular homeostasis. Ribosome-associated chaperones assist in this process, but coordination between their recruitment and translation initiation remains poorly understood. We report here that specific binding sites for eukaryotic translation initiation factor eIF3 within the 5’ untranslated regions (5’UTRs) of mRNAs promote its retention on 80S ribosomes during the synthesis of select endoplasmic reticulum (ER) membrane proteins. Disruption of these eIF3 binding sites leads to misfolding and sequestration of newly synthesized membrane proteins into ER whorls. Sequestration into ER whorls is exacerbated by HSP70 inhibition but can be rescued by overexpressing HSPA8 and HSPA1. Cross-linking assays reveal that 5’UTR binding sites stabilize eIF3–80S interactions during early elongation, facilitating recruitment of HSPA8 to ribosomes. These findings indicate that genetic instructions within 5’UTRs direct eIF3-mediated chaperone recruitment, ensuring proper co-translational folding of ER membrane proteins.
- Open Access
- 8 May 2023
- Published by Springer Nature in The EMBO Journal
- Vol. 42 (12) , e112362
eIF3 mRNA selectivity profiling reveals eIF3k as a cancer‐relevant regulator of ribosome content
EIF3, whose subunits are frequently overexpressed in cancer, regulates mRNA translation from initiation to termination, but mRNA-selective functions of individual subunits remain poorly defined. Using multiomic profiling upon acute depletion of eIF3 subunits, we observed that while eIF3a, b, e, and f markedly differed in their impact on eIF3 holo-complex formation and translation, they were each required for cancer cell proliferation and tumor growth. Remarkably, eIF3k showed the opposite pattern with depletion promoting global translation, cell proliferation, tumor growth, and stress resistance through repressing the synthesis of ribosomal proteins, especially RPS15A. Whereas ectopic expression of RPS15A mimicked the anabolic effects of eIF3k depletion, disruption of eIF3 binding to the 5'-UTR of RSP15A mRNA negated them. eIF3k and eIF3l are selectively downregulated in response to endoplasmic reticulum and oxidative stress. Supported by mathematical modeling, our data uncover eIF3k-l as a mRNA-specific module which, through controlling RPS15A translation, serves as a rheostat of ribosome content, possibly to secure spare translational capacity that can be mobilized during stress.
- 8 May 2023
- Published by Springer Nature in The EMBO Journal
- Vol. 42 (12) , e112362
Open AccesseIF3 mRNA selectivity profiling reveals eIF3k as a cancer‐relevant regulator of ribosome content
EIF3, whose subunits are frequently overexpressed in cancer, regulates mRNA translation from initiation to termination, but mRNA-selective functions of individual subunits remain poorly defined. Using multiomic profiling upon acute depletion of eIF3 subunits, we observed that while eIF3a, b, e, and f markedly differed in their impact on eIF3 holo-complex formation and translation, they were each required for cancer cell proliferation and tumor growth. Remarkably, eIF3k showed the opposite pattern with depletion promoting global translation, cell proliferation, tumor growth, and stress resistance through repressing the synthesis of ribosomal proteins, especially RPS15A. Whereas ectopic expression of RPS15A mimicked the anabolic effects of eIF3k depletion, disruption of eIF3 binding to the 5'-UTR of RSP15A mRNA negated them. eIF3k and eIF3l are selectively downregulated in response to endoplasmic reticulum and oxidative stress. Supported by mathematical modeling, our data uncover eIF3k-l as a mRNA-specific module which, through controlling RPS15A translation, serves as a rheostat of ribosome content, possibly to secure spare translational capacity that can be mobilized during stress.
- Open Access
NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma
SUMMARY: ∼30% of clear cell renal cell carcinoma (ccRCC) patients present with metastatic disease at the time of diagnosis, causing a dire 5-year survival rate of 13%. Whereas anti-PD-1 immunotherapy has improved survival, a strong need remains for new therapeutic options. Using integrated network analysis, we identified the mitotic regulator NDC80 as a predictor of ccRCC progression. Overexpression of NDC80 fosters the malignant phenotype by promoting cell cycle progression through S phase as well as boosting glycolysis and mitochondrial respiration. Despite high levels of immune infiltration, particularly derived from tumor resident CD8+ T cells with an exhausted phenotype, NDC80 defines a class of ccRCCs that poorly respond to immune checkpoint blockade. Instead, bioinformatics identified NDC80-high ccRCCs as sensitive to inhibitors of mitotic kinases, PLK1 and AURK, therapeutic approaches we validated in cell lines and mouse xenograft studies. Thus, NDC80 status pinpoints mitotic kinase inhibitors as promising therapeutic options in difficult-to-treat ccRCCs.
Open AccessNDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma
SUMMARY: ∼30% of clear cell renal cell carcinoma (ccRCC) patients present with metastatic disease at the time of diagnosis, causing a dire 5-year survival rate of 13%. Whereas anti-PD-1 immunotherapy has improved survival, a strong need remains for new therapeutic options. Using integrated network analysis, we identified the mitotic regulator NDC80 as a predictor of ccRCC progression. Overexpression of NDC80 fosters the malignant phenotype by promoting cell cycle progression through S phase as well as boosting glycolysis and mitochondrial respiration. Despite high levels of immune infiltration, particularly derived from tumor resident CD8+ T cells with an exhausted phenotype, NDC80 defines a class of ccRCCs that poorly respond to immune checkpoint blockade. Instead, bioinformatics identified NDC80-high ccRCCs as sensitive to inhibitors of mitotic kinases, PLK1 and AURK, therapeutic approaches we validated in cell lines and mouse xenograft studies. Thus, NDC80 status pinpoints mitotic kinase inhibitors as promising therapeutic options in difficult-to-treat ccRCCs.
- 1 March 2022
- Published by Elsevier in Cell Chemical Biology
- Vol. 29 (3) , 436-450.e15
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I
- 1 March 2022
- Published by Elsevier in Cell Chemical Biology
- Vol. 29 (3) , 436-450.e15
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I
- Open Access
- 19 May 2021
- Published by Springer Nature in The EMBO Journal
- Vol. 40 (13) , e106183
Dual roles of HSP70 chaperone HSPA1 in quality control of nascent and newly synthesized proteins
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 19 May 2021
- Published by Springer Nature in The EMBO Journal
- Vol. 40 (13) , e106183
Open AccessDual roles of HSP70 chaperone HSPA1 in quality control of nascent and newly synthesized proteins
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- Open Access
- 1 January 2021
- Published by Elsevier in Cell Reports
- Vol. 34 (4) , 108662
CSN7B defines a variant COP9 signalosome complex with distinct function in DNA damage response
- 1 January 2021
- Published by Elsevier in Cell Reports
- Vol. 34 (4) , 108662
Open AccessCSN7B defines a variant COP9 signalosome complex with distinct function in DNA damage response
- 1 August 2020
- Published by Elsevier in Molecular Cell
- Vol. 79 (4) , 575-587.e7
eIF3 Associates with 80S Ribosomes to Promote Translation Elongation, Mitochondrial Homeostasis, and Muscle Health
- 1 August 2020
- Published by Elsevier in Molecular Cell
- Vol. 79 (4) , 575-587.e7
eIF3 Associates with 80S Ribosomes to Promote Translation Elongation, Mitochondrial Homeostasis, and Muscle Health
- Open Access
- 11 July 2020
- Published by Cold Spring Harbor Laboratory in bioRxiv
Dual cooperation between HSP70 and the 26S proteasome in co-translational protein quality control
Co-translational degradation via the ubiquitin-proteasome system mediates quality control of 15 – 25% of nascent proteins, a proportion that is known to increase dramatically as a result of proteotoxic stress. Whereas the ubiquitylation machinery involved has been characterized, mechanisms coordinating the proteasomal destruction of ribosome-attached nascent proteins remain poorly defined. In pursuit of such mechanisms, we discovered dual cooperation of the HSP70 family member HSPA1 with the 26S proteasome: First, in response to proteotoxic stress, HSPA1 promotes proteasome recruitment to translating 80S ribosomes in a manner independent of nascent chain ubiquitylation. Secondly, HSPA1, in association with its cognate nucleotide exchange factor HSPH1, maintains co-translationally ubiquitylated proteins in a soluble state required for efficient proteasomal degradation. Both mechanisms conspire to confer thermotolerance to cells and to promote the growth of esophageal cancer cells in vitro and in animals. Consistent with these observations, HSPH1 knockout impedes tumor growth in vitro and in animals and correlates with favorable prognosis in digestive tract cancers, thus nominating HSPH1 as a cancer drug target.Highlights: Proteotoxic stress causes translational arrest, co-translational protein ubiquitylation, and proteasome recruitment to ribosomes Co-translational proteasome recruitment is independent of nascent chain ubiquitylation but is augmented by HSPA1 HSPA1-HSPH1 disaggregase confers thermotolerance by maintaining the solubility and proteasomal clearance of ubiquitylated proteins Low HSPH1 impedes co-translational thermotolerance and tumor growth and correlates with favorable prognosis in various cancers
- 11 July 2020
- Published by Cold Spring Harbor Laboratory in bioRxiv
Open AccessDual cooperation between HSP70 and the 26S proteasome in co-translational protein quality control
Co-translational degradation via the ubiquitin-proteasome system mediates quality control of 15 – 25% of nascent proteins, a proportion that is known to increase dramatically as a result of proteotoxic stress. Whereas the ubiquitylation machinery involved has been characterized, mechanisms coordinating the proteasomal destruction of ribosome-attached nascent proteins remain poorly defined. In pursuit of such mechanisms, we discovered dual cooperation of the HSP70 family member HSPA1 with the 26S proteasome: First, in response to proteotoxic stress, HSPA1 promotes proteasome recruitment to translating 80S ribosomes in a manner independent of nascent chain ubiquitylation. Secondly, HSPA1, in association with its cognate nucleotide exchange factor HSPH1, maintains co-translationally ubiquitylated proteins in a soluble state required for efficient proteasomal degradation. Both mechanisms conspire to confer thermotolerance to cells and to promote the growth of esophageal cancer cells in vitro and in animals. Consistent with these observations, HSPH1 knockout impedes tumor growth in vitro and in animals and correlates with favorable prognosis in digestive tract cancers, thus nominating HSPH1 as a cancer drug target.Highlights: Proteotoxic stress causes translational arrest, co-translational protein ubiquitylation, and proteasome recruitment to ribosomes Co-translational proteasome recruitment is independent of nascent chain ubiquitylation but is augmented by HSPA1 HSPA1-HSPH1 disaggregase confers thermotolerance by maintaining the solubility and proteasomal clearance of ubiquitylated proteins Low HSPH1 impedes co-translational thermotolerance and tumor growth and correlates with favorable prognosis in various cancers
- Open Access
- 10 April 2020
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 12 (6) , 403-409
eIF-Three to Tango: emerging functions of translation initiation factor eIF3 in protein synthesis and disease
Studies over the past three years have substantially expanded the involvements of eukaryotic initiation factor 3 (eIF3) in messenger RNA (mRNA) translation. It now appears that this multi-subunit complex is involved in every possible form of mRNA translation, controlling every step of protein synthesis from initiation to elongation, termination, and quality control in positive as well as negative fashion. Through the study of eIF3, we are beginning to appreciate protein synthesis as a highly integrated process coordinating protein production with protein folding, subcellular targeting, and degradation. At the same time, eIF3 subunits appear to have specific functions that probably vary between different tissues and individual cells. Considering the broad functions of eIF3 in protein homeostasis, it comes as little surprise that eIF3 is increasingly implicated in major human diseases and first attempts at therapeutically targeting eIF3 have been undertaken. Much remains to be learned, however, about subunit- and tissue-specific functions of eIF3 in protein synthesis and disease and their regulation by environmental conditions and post-translational modifications.
- 10 April 2020
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 12 (6) , 403-409
Open AccesseIF-Three to Tango: emerging functions of translation initiation factor eIF3 in protein synthesis and disease
Studies over the past three years have substantially expanded the involvements of eukaryotic initiation factor 3 (eIF3) in messenger RNA (mRNA) translation. It now appears that this multi-subunit complex is involved in every possible form of mRNA translation, controlling every step of protein synthesis from initiation to elongation, termination, and quality control in positive as well as negative fashion. Through the study of eIF3, we are beginning to appreciate protein synthesis as a highly integrated process coordinating protein production with protein folding, subcellular targeting, and degradation. At the same time, eIF3 subunits appear to have specific functions that probably vary between different tissues and individual cells. Considering the broad functions of eIF3 in protein homeostasis, it comes as little surprise that eIF3 is increasingly implicated in major human diseases and first attempts at therapeutically targeting eIF3 have been undertaken. Much remains to be learned, however, about subunit- and tissue-specific functions of eIF3 in protein synthesis and disease and their regulation by environmental conditions and post-translational modifications.